FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283591182> ?p ?o ?g. }

• W4283591182 endingPage "577" @default.
• W4283591182 startingPage "569" @default.
• W4283591182 abstract "Docetaxel (DTX) is a taxane chemotherapy agent used to treat many types of cancers, including esophageal squamous cell carcinoma. Adenosine is a purinergic signaling molecule that contributes to cancer cell proliferation via A2B adenosine receptor (A2BAR) activation. Extracellular signal-regulated protein kinase (ERK) plays a crucial role in cell proliferation in various types of cancers. Stimulation of A2BAR involves a regulated ERK signaling pathway, and might provide a fascinating approach for treatment, leading to decreased proliferation in certain tumors that express A2BAR. Recent studies demonstrated that DTX and A2BAR have anticancer effects. The current study was designed to investigate the synergistic effect of the A2BAR agonist (BAY606583) on DTX in inducing antiproliferation effects on esophageal squamous cells carcinoma (ESCCs). The cell viability was assessed using the MTT assay in KYSE-30 and Ym-1 cells. In addition, the synergistic effect of DTX on the A2BAR agonist was evaluated. Subsequently, apoptosis was assessed by Annexin-V and propidium iodide staining, and Bcl-2, Bax, and ERK1/2 protein-level expressions were evaluated by Western blot. Use of BAY606583 and cotreatment of DTX and BAY606583 significantly decreased cell proliferation in KYSE-30 and Ym-1 cell lines. The use of BAY606583 and cotreatment of DTX with the A2BAR agonist induced apoptosis in KYSE-30 and Ym-1 cells. Western blot analysis revealed that the use of the A2BAR agonist and cotreatment of DTX with the A2BAR agonist inhibited the expression of apoptotic regulatory proteins as well as the expression of ERK1/2 proteins. Our findings suggested that use of BAY606583 and cotreatment of BAY606583/DTX have an antiproliferative effect on ESCC cell lines through ERK signaling pathway inhibition. BAY606583 has a synergistic effect on DTX, which could be used as an adjuvant for esophageal cancer therapy." @default.
• W4283591182 created "2022-06-28" @default.
• W4283591182 creator A5000509360 @default.
• W4283591182 creator A5022647529 @default.
• W4283591182 creator A5022700559 @default.
• W4283591182 date "2022-06-27" @default.
• W4283591182 modified "2023-10-16" @default.
• W4283591182 title "Synergistic effects of BAY606583 on docetaxel in esophageal cancer through modulation of ERK1/2" @default.
• W4283591182 cites W1882528117 @default.
• W4283591182 cites W1969281636 @default.
• W4283591182 cites W1969645708 @default.
• W4283591182 cites W1970226410 @default.
• W4283591182 cites W1988268018 @default.
• W4283591182 cites W1992868626 @default.
• W4283591182 cites W2023384375 @default.
• W4283591182 cites W2047246023 @default.
• W4283591182 cites W2047423878 @default.
• W4283591182 cites W2051122069 @default.
• W4283591182 cites W2077945404 @default.
• W4283591182 cites W2081236313 @default.
• W4283591182 cites W2083056701 @default.
• W4283591182 cites W2087861588 @default.
• W4283591182 cites W2103562758 @default.
• W4283591182 cites W2107277218 @default.
• W4283591182 cites W2119829982 @default.
• W4283591182 cites W2128941584 @default.
• W4283591182 cites W2133929108 @default.
• W4283591182 cites W2136467127 @default.
• W4283591182 cites W2147152447 @default.
• W4283591182 cites W2159945718 @default.
• W4283591182 cites W2539605271 @default.
• W4283591182 cites W2772094867 @default.
• W4283591182 cites W2783916485 @default.
• W4283591182 cites W2789563027 @default.
• W4283591182 cites W2791846524 @default.
• W4283591182 cites W2887494686 @default.
• W4283591182 cites W2888875920 @default.
• W4283591182 cites W2951761618 @default.
• W4283591182 cites W2970118391 @default.
• W4283591182 cites W2988407093 @default.
• W4283591182 cites W3120946713 @default.
• W4283591182 doi "https://doi.org/10.1002/cbf.3726" @default.
• W4283591182 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35758556" @default.
• W4283591182 hasPublicationYear "2022" @default.
• W4283591182 type Work @default.
• W4283591182 citedByCount "0" @default.
• W4283591182 crossrefType "journal-article" @default.
• W4283591182 hasAuthorship W4283591182A5000509360 @default.
• W4283591182 hasAuthorship W4283591182A5022647529 @default.
• W4283591182 hasAuthorship W4283591182A5022700559 @default.
• W4283591182 hasConcept C121608353 @default.
• W4283591182 hasConcept C126322002 @default.
• W4283591182 hasConcept C134018914 @default.
• W4283591182 hasConcept C170493617 @default.
• W4283591182 hasConcept C185592680 @default.
• W4283591182 hasConcept C190283241 @default.
• W4283591182 hasConcept C2775934118 @default.
• W4283591182 hasConcept C2776991684 @default.
• W4283591182 hasConcept C2778938600 @default.
• W4283591182 hasConcept C2781190966 @default.
• W4283591182 hasConcept C31573885 @default.
• W4283591182 hasConcept C502942594 @default.
• W4283591182 hasConcept C55493867 @default.
• W4283591182 hasConcept C57074206 @default.
• W4283591182 hasConcept C62112901 @default.
• W4283591182 hasConcept C62478195 @default.
• W4283591182 hasConcept C67907053 @default.
• W4283591182 hasConcept C71924100 @default.
• W4283591182 hasConcept C75217442 @default.
• W4283591182 hasConcept C86803240 @default.
• W4283591182 hasConcept C95444343 @default.
• W4283591182 hasConcept C98274493 @default.
• W4283591182 hasConceptScore W4283591182C121608353 @default.
• W4283591182 hasConceptScore W4283591182C126322002 @default.
• W4283591182 hasConceptScore W4283591182C134018914 @default.
• W4283591182 hasConceptScore W4283591182C170493617 @default.
• W4283591182 hasConceptScore W4283591182C185592680 @default.
• W4283591182 hasConceptScore W4283591182C190283241 @default.
• W4283591182 hasConceptScore W4283591182C2775934118 @default.
• W4283591182 hasConceptScore W4283591182C2776991684 @default.
• W4283591182 hasConceptScore W4283591182C2778938600 @default.
• W4283591182 hasConceptScore W4283591182C2781190966 @default.
• W4283591182 hasConceptScore W4283591182C31573885 @default.
• W4283591182 hasConceptScore W4283591182C502942594 @default.
• W4283591182 hasConceptScore W4283591182C55493867 @default.
• W4283591182 hasConceptScore W4283591182C57074206 @default.
• W4283591182 hasConceptScore W4283591182C62112901 @default.
• W4283591182 hasConceptScore W4283591182C62478195 @default.
• W4283591182 hasConceptScore W4283591182C67907053 @default.
• W4283591182 hasConceptScore W4283591182C71924100 @default.
• W4283591182 hasConceptScore W4283591182C75217442 @default.
• W4283591182 hasConceptScore W4283591182C86803240 @default.
• W4283591182 hasConceptScore W4283591182C95444343 @default.
• W4283591182 hasConceptScore W4283591182C98274493 @default.
• W4283591182 hasFunder F4320324866 @default.
• W4283591182 hasIssue "6" @default.
• W4283591182 hasLocation W42835911821 @default.
• W4283591182 hasLocation W42835911822 @default.

• next